$1.10
-0.05-4.24%
Last update: 2:28 PM
15 minutes delayed
Protalix BioTherapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Protalix BioTherapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-14 | $-0.03 | $0.02 | -250.0 % |
Mar 2024 | 2024-05-10 | $-0.06 | $-0.02 | -200.0 % |
Dec 2023 | 2024-03-14 | $-0.07 | $-0.03 | -133.3 % |
Sep 2023 | 2023-11-06 | $-0.04 | $-0.04 | 0.00 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-14 | $13.47M | $12.50M | 7.79 % |
Mar 2024 | 2024-05-10 | $3.75M | $9.20M | -59.3 % |
Dec 2023 | 2024-03-14 | $10.49M | $5.80M | 80.8 % |
Sep 2023 | 2023-11-06 | $10.35M | $10.00M | 3.45 % |
Protalix BioTherapeutics (PLX) is scheduled to report earnings on November 4, 2024. The last reported earnings were for reported on August 14, 2024 for Q2.
The Actual EPS was $-0.03, which missed the estimate of $0.02.
The Actual Revenue was $13.5M, which beat the estimate of $12.5M.
Browse earnings estimates, EPS, and revenue on all stocks.